[HTML][HTML] Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of …
…, S Kaur, P Lanham, N Morant, J Richards, P Shah… - The Lancet, 2015 - thelancet.com
Background Individuals with a history of recurrent depression have a high risk of repeated
depressive relapse or recurrence. Maintenance antidepressants for at least 2 years is the …
depressive relapse or recurrence. Maintenance antidepressants for at least 2 years is the …
Patient-nurse interrater reliability and agreement of the Richards-Campbell sleep questionnaire
Background The Richards-Campbell Sleep Questionnaire (RCSQ) is a simple, validated
survey instrument for measuring sleep quality in intensive care patients. Although both patients …
survey instrument for measuring sleep quality in intensive care patients. Although both patients …
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor
…, H Bernard, X Yang, H Liao, C Rabino, P Shah… - Nature chemical …, 2017 - nature.com
Small ubiquitin-like modifier (SUMO) family proteins regulate target-protein functions by post-translational
modification. However, a potent and selective inhibitor targeting the SUMO …
modification. However, a potent and selective inhibitor targeting the SUMO …
[PDF][PDF] Comparative study of DPPH, ABTS and FRAP assays for determination of antioxidant activity
P Shah, HA Modi - Int. J. Res. Appl. Sci. Eng. Technol, 2015 - researchgate.net
Three simple spectrophotometric methods:(1, 1-diphenyl-2-picrylhydrazyl) free radical
scavenging activity assay (DPPH),[2, 2’-azinobis (3-ethylbenzothiazoline-6-sulphonic acid)] free …
scavenging activity assay (DPPH),[2, 2’-azinobis (3-ethylbenzothiazoline-6-sulphonic acid)] free …
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models
SUMOylation, the covalent conjugation of small ubiquitin-like modifier (SUMO) proteins to
protein substrates, has been reported to suppress type I interferon (IFN1) responses. TAK-981, …
protein substrates, has been reported to suppress type I interferon (IFN1) responses. TAK-981, …
[HTML][HTML] NOTCH1 signaling in head and neck squamous cell carcinoma
Biomarker-driven targeted therapies are lacking for head and neck squamous cell carcinoma
(HNSCC), which is common and lethal. Efforts to develop such therapies are hindered by a …
(HNSCC), which is common and lethal. Efforts to develop such therapies are hindered by a …
SMAD4 suppresses WNT-driven dedifferentiation and oncogenesis in the differentiated gut epithelium
The cell of origin of colon cancer is typically thought to be the resident somatic stem cells,
which are immortal and escape the continual cellular turnover characteristic of the intestinal …
which are immortal and escape the continual cellular turnover characteristic of the intestinal …
Enhanced recovery implementation in major gynecologic surgeries: effect of care standardization
…, ER Trowbridge, DL Redick, PM Shah… - Obstetrics & …, 2016 - journals.lww.com
OBJECTIVE: To examine implementing an enhanced recovery after surgery (ERAS) protocol
for women undergoing major gynecologic surgery at an academic institution and compare …
for women undergoing major gynecologic surgery at an academic institution and compare …
[HTML][HTML] Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation
…, SM Pulukuri, S Grossman, V Shinde, P Shah… - PloS one, 2015 - journals.plos.org
SUMOylation is a post-translational ubiquitin-like protein modification pathway that
regulates important cellular processes including chromosome structure, kinetochore function, …
regulates important cellular processes including chromosome structure, kinetochore function, …
[HTML][HTML] Novel systemic treatment modalities including immunotherapy and molecular targeted therapy for recurrent and metastatic head and neck squamous cell …
Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancers
worldwide. More than half of patients with HNSCC eventually experience disease recurrence …
worldwide. More than half of patients with HNSCC eventually experience disease recurrence …